{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T20:03:57Z","timestamp":1791057837391,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2001,2,1]],"date-time":"2001-02-01T00:00:00Z","timestamp":980985600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2001,2,1]],"date-time":"2001-02-01T00:00:00Z","timestamp":980985600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2001,2,1]]},"DOI":"10.1038\/sj.gt.3301398","type":"journal-article","created":{"date-parts":[[2002,9,4]],"date-time":"2002-09-04T16:57:42Z","timestamp":1031158662000},"page":"308-315","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":248,"title":["Safety and feasibility of injection with an E1B-55 kDa gene-deleted, replication-selective adenovirus (ONYX-015) into primary carcinomas of the pancreas: a phase I trial"],"prefix":"10.1038","volume":"8","author":[{"given":"S","family":"Mulvihill","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Warren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Venook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Adler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Randlev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Heise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Kirn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2001,4,17]]},"reference":[{"key":"BF3301398_CR1","first-page":"1054","volume-title":"Cancer: Principles and Practice of Oncology","author":"J Abbruzzese","year":"1997","unstructured":"Abbruzzese J, Evans D, Rich T . Cancer of the pancreas. In: V DeVita, S Hellman, S Rosenberg (eds) Cancer: Principles and Practice of Oncology 5th edn: Lippincott-Raven: Philadelphia 1997 pp 1054\u20131086"},{"key":"BF3301398_CR2","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1200\/JCO.1997.15.6.2403","volume":"15","author":"H Burris","year":"1997","unstructured":"Burris H et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial J Clin Oncol 1997 15: 2403\u20132413","journal-title":"J Clin Oncol"},{"key":"BF3301398_CR3","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1038\/bjc.1991.467","volume":"64","author":"CM Barton","year":"1991","unstructured":"Barton CM et al. Abnormalities of the p53 tumour suppressor gene in human pancreatic cancer Br J Cancer 1991 64: 1076\u20131082","journal-title":"Br J Cancer"},{"key":"BF3301398_CR4","first-page":"1556","volume":"54","author":"N Pellegata","year":"1994","unstructured":"Pellegata N et al. K-ras and p53 mutations in pancreatic cancer: ductal and non-ductal tumors progress through different genetic lesions Cancer Res 1994 54: 1556\u20131562","journal-title":"Cancer Res"},{"key":"BF3301398_CR5","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1200\/JCO.1995.13.4.1009","volume":"13","author":"F Chang","year":"1995","unstructured":"Chang F, Syrjanen S, Syrjanen K . Implications of the p53 tumor-suppressor gene in clinical oncology J Clin Oncol 1995 13: 1009\u20131022","journal-title":"J Clin Oncol"},{"key":"BF3301398_CR6","doi-asserted-by":"publisher","first-page":"2779","DOI":"10.1038\/sj.onc.1202501","volume":"17","author":"S Vonlanthen","year":"1998","unstructured":"Vonlanthen S et al. Expression of p16INK4ap16alpha and p19ARF\/p16beta is frequently altered in non-small cell lung cancer and correlates with p53 overexpression Oncogene 1998 17: 2779\u20132785","journal-title":"Oncogene"},{"key":"BF3301398_CR7","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/S0092-8674(00)81401-4","volume":"92","author":"Y Zhang","year":"1998","unstructured":"Zhang Y, Xiong Y, Yarbrough WG . ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways Cell 1998 92: 725\u2013734","journal-title":"Cell"},{"key":"BF3301398_CR8","first-page":"2231","volume":"53","author":"FS Leach","year":"1993","unstructured":"Leach FS et al. p53 mutation and MDM2 amplification in human soft tissue sarcomas Cancer Res 1993 53: 2231\u20132234","journal-title":"Cancer Res"},{"key":"BF3301398_CR9","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1038\/nm1095-1029","volume":"1","author":"J Bergh","year":"1995","unstructured":"Bergh J et al. Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy Nat Med 1995 1: 1029\u20131034","journal-title":"Nat Med"},{"key":"BF3301398_CR10","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/nm0697-639","volume":"3","author":"C Heise","year":"1997","unstructured":"Heise C et al. ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents Nat Med 1997 3: 639\u2013645","journal-title":"Nat Med"},{"key":"BF3301398_CR11","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1126\/science.274.5286.373","volume":"274","author":"JR Bischoff","year":"1996","unstructured":"Bischoff JR et al. An adenovirus mutant that replicates selectively in p53-deficient human tumor cells Science 1996 274: 373\u2013376","journal-title":"Science"},{"key":"BF3301398_CR12","first-page":"2623","volume":"59","author":"C Heise","year":"1999","unstructured":"Heise C et al. Intravenous administration of ONYX-015, a selectively-replicating adenovirus, induces antitumoral efficacy Cancer Res 1999 59: 2623\u20132628","journal-title":"Cancer Res"},{"key":"BF3301398_CR13","first-page":"391a","volume":"17","author":"D Kirn","year":"1998","unstructured":"Kirn D et al. A phase II trial of intratumoral injection with an E1B-deleted adenovirus, ONYX-015, in patients with recurrent, refractory head and neck cancer Proc Am Soc Clin Oncol 1998 17: 391a","journal-title":"Proc Am Soc Clin Oncol"},{"key":"BF3301398_CR14","first-page":"798","volume":"6","author":"I Ganly","year":"2000","unstructured":"Ganly I et al. A phase I study of Onyx-015, an E1B attenuated adenovirus, administered intratumorally to patients with recurrent head and neck cancer Clin Cancer Res 2000 6: 798\u2013806","journal-title":"Clin Cancer Res"},{"key":"BF3301398_CR15","first-page":"958 (Abstr.)","volume":"19","author":"T Reid","year":"2000","unstructured":"Reid T et al. Hepatic arterial infusion of a replication-selective adenovirus. Onyx-015: a phase I\/II clinical trial Proc Am Soc Clin Oncol 2000 19: 958 (Abstr.)","journal-title":"Proc Am Soc Clin Oncol"},{"key":"BF3301398_CR16","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1038\/78638","volume":"6","author":"F Khuri","year":"2000","unstructured":"Khuri F et al. A controlled clinical trial of intratumoral Onyx-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer Nat Med 2000 6: 879\u2013885","journal-title":"Nat Med"},{"key":"BF3301398_CR17","first-page":"798","volume":"6","author":"I Ganly","year":"2000","unstructured":"Ganly I et al. A phase I clinical trial with ONYX-015 (a selectively replicating adenovirus) administered by intratumoral injection in patients with recurrent head and neck cancer Clin Cancer Res 2000 6: 798\u2013806","journal-title":"Clin Cancer Res"},{"key":"BF3301398_CR18","doi-asserted-by":"publisher","first-page":"6196","DOI":"10.1073\/pnas.91.13.6196","volume":"91","author":"JF Engelhardt","year":"1994","unstructured":"Engelhardt JF, Ye X, Doranz B, Wilson JM . Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver Proc Natl Acad Sci USA 1994 91: 6196\u20136200","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3301398_CR19","first-page":"106","volume":"3","author":"LR Gooding","year":"1994","unstructured":"Gooding LR . Regulation of TNF-mediated cell death and inflammation by human adenoviruses Infect Agents Dis 1994 3: 106\u2013115","journal-title":"Infect Agents Dis"},{"key":"BF3301398_CR20","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/ng0794-362","volume":"7","author":"Y Yang","year":"1994","unstructured":"Yang Y et al. Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis Nat Genet 1994 7: 362\u2013369","journal-title":"Nat Genet"},{"key":"BF3301398_CR21","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1073\/pnas.88.5.1651","volume":"88","author":"HS Ginsberg","year":"1991","unstructured":"Ginsberg HS et al. A mouse model for investigating the molecular pathogenesis of adenovirus pneumonia Proc Natl Acad Sci USA 1991 88: 1651\u20131655","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3301398_CR22","doi-asserted-by":"publisher","first-page":"6191","DOI":"10.1073\/pnas.87.16.6191","volume":"87","author":"HS Ginsberg","year":"1990","unstructured":"Ginsberg HS, Horswood RL, Chanock RM, Prince GA . Role of early genes in pathogenesis of adenovirus pneumonia (published erratum appears in Proc Natl Acad Sci USA 1991; 88: 681) Proc Natl Acad Sci USA 1990 87: 6191\u20136195","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3301398_CR23","doi-asserted-by":"publisher","first-page":"3823","DOI":"10.1073\/pnas.86.10.3823","volume":"86","author":"HS Ginsberg","year":"1989","unstructured":"Ginsberg HS et al. Role of early region 3 (E3) in pathogeneis of adenovirus disease Proc Natl Acad Sci USA 1989 86: 3823\u20133827","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3301398_CR24","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/sj.cgt.7700071","volume":"6","author":"C Heise","year":"1999","unstructured":"Heise C, Williams A, Olesch J, Kirn D . Efficacy of a replication-competent adenovirus (ONYX-015) following intratumoral injection: intratumoral spread and distribution effects Cancer Gene Therapy 1999 6: 499\u2013503","journal-title":"Cancer Gene Therapy"},{"key":"BF3301398_CR25","first-page":"186 (Abstr.)","volume":"18","author":"JR Hecht","year":"1999","unstructured":"Hecht JR et al. A phase I study of multiple direct injections of ONYX-015 adenovirus under endoscopic ultrasound guidance Proc Am Soc Clin Oncol 1999 18: 186 (Abstr.)","journal-title":"Proc Am Soc Clin Oncol"},{"key":"BF3301398_CR26","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1172\/JCI9761","volume":"105","author":"D Kirn","year":"2000","unstructured":"Kirn D . Replication-selective micro-organisms: fighting cancer with targeted germ warfare J Clin Invest 2000 105: 836\u2013838","journal-title":"J Clin Invest"},{"key":"BF3301398_CR27","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/0042-6822(87)90441-7","volume":"156","author":"DD Barker","year":"1987","unstructured":"Barker DD, Berk AJ . Adenovirus proteins from both E1B reading frames are required for transformation of rodent cells by viral infection and DNA transfection Virology 1987 156: 107\u2013121","journal-title":"Virology"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/3301398.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/3301398","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/3301398.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T01:31:07Z","timestamp":1648603867000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/3301398"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,2,1]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2001,2,1]]}},"alternative-id":["BF3301398"],"URL":"https:\/\/doi.org\/10.1038\/sj.gt.3301398","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,2,1]]},"assertion":[{"value":"22 August 2000","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2000","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2001","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}